Microplate readers are the workhorses of early stage drug discovery. However, they are often used only for endpoint assays. While automation can force large numbers of samples through these workflows, this approach is problematic for discovery-based applications where the timing and duration of effects are unknown.
This webinar sponsored by BMG LABTECH will explore how advanced plate readers and assay technologies move beyond high-throughput endpoint studies to enable continuous monitoring of metabolic activity dynamics, transcriptional regulation, foreign gene expression, and cellular health. By expressing a synthetic luciferase that does not require external excitation, researchers can induce cellular targets to continuously modulate their bioluminescent signals. With atmospheric control and flexible programming, modern microplate readers can quickly and inexpensively obtain more data earlier in the pipeline.
Dan Close, PhD
Chief Scientific Officer
Lead Scientist for Cellular Technologies
Carl Peters, PhD
Senior Application Specialist
BMG LABTECH USA
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.